Iterion Therapeutics
Latest round
- Series B
Last raised
- Feb 2021
Total raised
- $24M
Investors
- 5
About Iterion Therapeutics
, operates as a biopharmaceutical company that develops novel targeted cancer therapeutics designed to treat a person with cancer. The company was co-founded by Rahul Aras, Steve Horrigan, and Sunil Sharma, and in February 2021, Iterion Therapeutics Inc. and Apollomics, Inc. announced an exclusive collaboration and license agreement to develop and commercialize tegavivint in Greater China. The company offers a cancer treatment called "Tegavivint" a beta-catenin and Wnt gene expression modulator that prevents cancer gene activation and maintains regular tissue function. The company's product also provides anti-tumor activity in multiple pre-clinical models, including acute myeloid leukemia (AML) and non-small cell lung cancer (NSCLC). Apollomics, Inc. and Iterion Therapeutics Inc. plans to expand clinical development for a potent and selective small-molecule targeting TBL1, a downstream target in the Wnt/ß-catenin signaling pathway.
Who invested in Iterion Therapeutics
5 investors across 3 rounds
See all investors in Iterion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Iterion Therapeutics
Who invested in Iterion Therapeutics?
Iterion Therapeutics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Iterion Therapeutics raised?
Iterion Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Iterion Therapeutics last raise money?
Iterion Therapeutics's most recent round on record is a Series B, in Feb 2021.
What does Iterion Therapeutics do?
, operates as a biopharmaceutical company that develops novel targeted cancer therapeutics designed to treat a person with cancer.
Where is Iterion Therapeutics headquartered?
Iterion Therapeutics is headquartered in Houston, US.
Which VCs invest in companies like Iterion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Iterion Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Iterion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.